pRESET
Showing 1 - 25 of 433
Age Related Cataracts, Pseudoexfoliation Syndrome Trial (Phakoemulsification, Ziemer Z8 Femtolaser, Kowa Avansee Preset)
Not yet recruiting
- Age Related Cataracts
- Pseudoexfoliation Syndrome
- Phakoemulsification
- +2 more
- (no location specified)
Sep 22, 2023
Carotid Artery Stenosis Trial in Camden (Remifentanil, Propofol, and Desflurane, Remifentanil, Dexmedetomidine, and Desflurane,
Completed
- Carotid Artery Stenosis
- Remifentanil, Propofol, and Desflurane
- +2 more
-
Camden, New JerseyCooper University Hospital
Mar 16, 2022
Chronic Pain Trial in Spartanburg (preset program)
Completed
- Chronic Pain
- preset program
-
Spartanburg, South CarolinaCarolinas Center For Advanced Management of Pain
Feb 22, 2021
Healthy Participants Trial in Gentofte (Standard mixed breakfast meal, SmartBar™)
Completed
- Healthy Participants
- Standard mixed breakfast meal
- SmartBar™
-
Gentofte, DenmarkSteno Diabetes Center Copenhagen
Jun 17, 2019
Food Reward and Food-related Behavior in Healthy Individuals
Completed
- Healthy Participants
-
Gentofte, DenmarkSteno Diabetes Center Copenhagen
Sep 2, 2019
Esketamine Trial (Subanesthetic dose of esketamine)
Not yet recruiting
- Esketamine
- Subanesthetic dose of esketamine
- (no location specified)
Jul 5, 2023
Balanced Propofol Sedation in Fiberoptic Bronchoscopy
Not yet recruiting
- Bronchoscopy
- Midazolam and sufentanil
- +4 more
- (no location specified)
Oct 29, 2023
Takayasu Arteritis Trial in Beijing (Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg)
Recruiting
- Takayasu Arteritis
- Tofacitinib 5 MG
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Feb 19, 2023
Lens Luxation, IOL Subluxation, IOL Opacification Trial in Vienna (Pars plana vitrectomy, IOL explantation, Scleral IOL fixation
Recruiting
- Lens Luxation
- +3 more
- Pars plana vitrectomy
- +3 more
-
Vienna, AustriaMedical University of Vienna
Oct 20, 2023
Advanced Solid Tumors Trial (SHR-A2009 for injection ; Almonertinib Mesilate Tablets, SHR-A2009 for injection;Adebrelimab
Not yet recruiting
- Advanced Solid Tumors
- SHR-A2009 for injection ； Almonertinib Mesilate Tablets
- SHR-A2009 for injection；Adebrelimab Injection
- (no location specified)
Oct 17, 2023
Cognitive Performance, Sleep, Alertness Trial (Biodynamic, Active Placebo)
Not yet recruiting
- Cognitive Performance
- +2 more
- Biodynamic
- Active Placebo
- (no location specified)
Jul 28, 2022
Atrial Fibrillation, Cathter Ablation, Endpoint Trial in Shanghai (AF-termination Group, Prespecified-ablation Group)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- AF-termination Group
- Prespecified-ablation Group
-
Shanghai, China
- +1 more
Jun 19, 2023
Advanced HCC Trial in Beijing (KN046 (PD-L1/CTLA4 BsAb), Ningetinib Tosylate(multi-target TKI))
Terminated
- Advanced HCC
- KN046 （PD-L1/CTLA4 BsAb）
- Ningetinib Tosylate（multi-target TKI）
-
Beijing, Beijing, ChinaChinese Pla General Hospital Chinese Pla Medical School
Oct 26, 2022
Gynecologic Cancer, Neuropathy;Peripheral Trial in Augusta (SensoniQ Treatment Station)
Not yet recruiting
- Gynecologic Cancer
- Neuropathy;Peripheral
- SensoniQ Treatment Station
-
Augusta, GeorgiaJames T Sonnenberg
Jul 31, 2023
Stroke Trial in Norwich (rehabilitation intervention)
Completed
- Stroke
- rehabilitation intervention
-
Norwich, United KingdomSarah Bajuaifer
Nov 5, 2021
Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)
Recruiting
- Early Alzheimer's Disease
- Experimental: ALZ-801
- Placebo Comparator: Placebo
-
Phoenix, Arizona
- +95 more
Aug 18, 2022
Advanced Gastrointestinal Tumors Trial in Shanghai (Donafenib Tosilate Tablets, KN046 Injection)
Recruiting
- Advanced Gastrointestinal Tumors
- Donafenib Tosilate Tablets
- KN046 Injection
-
Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Nov 28, 2022
Intervention Trial in Hefei (transcutaneous auricular vagus nerve stimulation)
Recruiting
- Intervention
- transcutaneous auricular vagus nerve stimulation
-
Hefei, Anhui, ChinaAnhui Medical University
Aug 31, 2023
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Pneumonia Hospital Acquired Trial in Cairo (The Incentive Spirometer, The breather respiratory muscle training device)
Completed
- Pneumonia Hospital Acquired
- The Incentive Spirometer
- The breather respiratory muscle training device
-
Cairo, EgyptFaculty of Physical Therapy - Cairo University
Sep 28, 2023
Lichen Sclerosus Trial in Winterthur (Treatment with Monalisa Glide Laser, Treatment with Clobetasol)
Recruiting
- Lichen Sclerosus
- Treatment with Monalisa Glide Laser
- Treatment with Clobetasol
-
Winterthur, Zürich, SwitzerlandKantonsspital Winterthur
Nov 14, 2023
CD20-positive Non-Hodgkin Lymphoma Trial in China (EX103 injection)
Recruiting
- CD20-positive Non-Hodgkin Lymphoma
- EX103 injection
-
Zhengzhou, Henan, China
- +3 more
Aug 28, 2023
Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)
Not yet recruiting
- Hematologic Neoplasms
- +5 more
- umbilical cord derived mesenchymal stem cells
-
Wuhan, Hubei, China
- +2 more
Jan 3, 2023
Diabetes, Type 2, Weight Change, Body Trial in Peshawar, Karachi (Semaglutide Pen Injector)
Recruiting
- Diabetes Mellitus, Type 2
- Weight Change, Body
- Semaglutide Pen Injector
-
Peshawar, KPK, Pakistan
- +1 more
Aug 3, 2022